Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 474-484

  Harris, P ^a   Sridhar, S ^a   Peng, R ^a   Phillips, J E ^a   Cohn, R G ^a   Burns, L ^a   Woods, J ^a   Ramanujam, M ^a   Loubeau, M ^a   Tyagi, G ^a   Allard, J ^a   Burczynski, M ^a   Ravindran, P ^a   Cheng, D ^a   Bitter, H ^a   Fine, J S ^a   Bauer, C M T ^a   Stevenson, C S ^a,b  

^a HOFFMANN LA ROCHE INC   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MOLECULAR MECHANICS; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION;

EID: 84876401694     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.86     Document Type: Article

References (40)

1. Mohan, A. et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 15, 536-542 (2010).
2. Rohde, G. et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58, 37-42 (2003).
3. Seemungal, T. et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1618-1623 (2001).
4. towell, N. C. et al. Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir. Res. 10, 43 (2009).
5. Groskreutz, D. J., Monick, M. M., Powers, L. S., Yarovinsky, T. O., Look, D. C. & Hunninghake, G. W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J. Immunol. 176, 1733-1740 (2006).
6. Le Goffi c, R. et al. Cutting edge: infl uenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178, 3368-3372 (2007).
7. Wang, Q. et al. MDA5 and TLR3 initiate pro-infl ammatory signaling pathways leading to rhinovirus-induced airways infl ammation and hyperresponsiveness. PLoS Pathogens 7, e1002070 (2011).
8. Kang, M. J. et al. Cigarette smoke selectively enhances viral PAMP-and virus-induced pulmonary innate immune and remodeling responses in mice. J. Clin. Invest. 118, 2771-2784 (2008).
9. GSVA-The Gene Set Variation Analysis Package. http://www.bioconductor. org/packages/2.8/bioc/html/GSVA.html 2011, Accessed Date Accessed 2011 Accessed.
10. Abbas, A. R., Wolslegel, K., Seshasayee, D., Modrusan, Z. & Clark, H. F. Deconvolution of blood microarray data identifi es cellular activation patterns in systemic lupus erythematosus. PloS One 4, e6098 (2009).
11. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
12. Chao, J. et al. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists. Bioorg. Med. Chem. Lett. 17, 3778-3783 (2007).
13. Baba, M. et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 96, 5698-5703 (1999).
14. Golpon, H. A. et al. Emphysema lung tissue gene expression profi ling. Am. J. Respir. Cell Mol. Biol. 31, 595-600 (2004).
15. Konishi, K. et al. Gene expression profi les of acute exacerbations of idiopathic pulmonary fi brosis. Am. J. Respir. Crit. Care Med. 180, 167-175 (2009).
16. Kohlmeier, J. E. et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29, 101-113 (2008).
17. Stein-Streilein, J., Bennett, M., Mann, D. & Kumar, V. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local infl uenza virus infection. J. Immunol. 131, 2699-2704 (1983).
18. Verbist, K. C., Field, M. B. & Klonowski, K. D. Cutting edge: IL-15- independent maintenance of mucosally generated memory CD8 T cells. J. Immunol. 186, 6667-6671 (2011).
19. Wareing, M. D., Shea, A. L., Inglis, C A., Dias, P. B. & Sarawar, S. R. CXCR2 is required for neutrophil recruitment to the lung during infl uenza virus infection, but is not essential for viral clearance. Viral. Immunol. 20, 369-378 (2007)
20. Weiss, G., Christensen, H. R., Zeuthen, L H., Vogensen, F. K., Jakobsen, M & Frokiaer, H. Lactobacilli and bifi dobacteria induce differential interferon-beta profi les in dendritic cells. Cytokine 56, 520-530 (2011)
21. Piqueras, B., Connolly, J., Freitas, H, Palucka, A. K. & Banchereau, J Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107, 2613-2618 (2006).
22. Tyner, J. W. et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 11, 1180-1187 (2005).
23. Kim, E. Y et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640 (2008)
24. Nagarkar, D. R. et al. CXCR2 is required for neutrophilic airway infl ammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J. Immunol. 183, 6698-6707 (2009).
25. Bartlett, N. W. et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway infl ammation. Nat. Med. 14, 199-204 (2008).
26. Graham, B. S., Perkins, M. D., Wright, P. F & Karzon, D. T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26, 153-162 (1988).
27. Holtzman, M. J. et al. Immune pathways for translating viral infection into chronic airway disease. Adv. Immunol. 102, 245-276 (2009)
28. Motz, G. T. et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J. Immunol. 184, 4460-4469 (2010)
29. Ma, B. et al. Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J. Clin. Invest. 115, 3460-3472 (2005)
30. Stevenson, CS et al. Characterization of cigarette smoke-induced infl ammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L514-L522 (2005).
31. Wan, W. Y et al. Pharmacological characterisation of anti-infl ammatory compounds in acute and chronic mouse models of cigarette smoke-induced infl ammation. Respir. Res. 11, 126 (2010).
32. Saetta, M. et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, 711-717 (1999)
33. Sikkel, M. B., Quint, J. K., Mallia, P., Wedzicha, J. A. & Johnston, S. L. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr. Infect. Dis. J. 27 (10 Suppl), S63-S70 (2008)
34. Barry, W. T., Nobel, A. B. & Wright, F A. Signifi cance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 21, 1943-1949 (2005)
35. Pavlidis, P., Qin, J., Arango, V, Mann, J. J. & Sibille, E. Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem. Res. 29, 1213-1222 (2004).
36. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profi les. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005)
37. Bild, A. H. et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357 (2006)
38. Gustafson, A. M. et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Translational Med. 2, 26ra25 (2010).
39. Konzett, H. R. Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur. Naunyn-Schmiedeberg's Arch. Pharmacol 195, 71-74 (1940).
40. Benjamini, Y & Hochberg, Y Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Met. 57, 289-300 (1995).